The surge in litigation surrounding Primary Central Nervous System (CNS) Lymphoma raises critical questions about the intersection of environmental exposures and severe health outcomes. As these cases gain momentum, individuals diagnosed with Primary CNS Lymphoma and their families are left to navigate a complex legal terrain, potentially implicating common substances such as pesticides in the pathogenesis of this debilitating disease. This exploration not only seeks to illuminate the intricacies of establishing causality in such lawsuits but also aims to foster a broader understanding of the legal mechanisms at play. The implications of these cases extend beyond the courtroom, touching on pivotal public health and policy considerations.<\/p>\n